| 注册
首页|期刊导航|中国全科医学|入院前使用二甲双胍对糖尿病合并脓毒症患者临床结局的影响

入院前使用二甲双胍对糖尿病合并脓毒症患者临床结局的影响

何宇福 佟文英 王芳 李丽霞 何俊冰 邵义明

中国全科医学2024,Vol.27Issue(9):1034-1041,8.
中国全科医学2024,Vol.27Issue(9):1034-1041,8.DOI:10.12114/j.issn.1007-9572.2023.0347

入院前使用二甲双胍对糖尿病合并脓毒症患者临床结局的影响

Effects of Pre-hospital Metformin Use on Clinical Outcomes in Patients with Diabetes and Sepsis

何宇福 1佟文英 1王芳 1李丽霞 1何俊冰 2邵义明3

作者信息

  • 1. 523940 广东省东莞市,广东医科大学附属东莞第一医院重症医学科||524000 广东省湛江市,广东医科大学研究生院
  • 2. 522000 广东省揭阳市人民医院揭阳市医学科研中心实验室
  • 3. 523940 广东省东莞市,广东医科大学附属东莞第一医院重症医学科
  • 折叠

摘要

Abstract

Background There is growing evidence that pre-hospital use of metformin reduces mortality in patients with diabetes and sepsis;however,the effect of metformin on clinical outcomes in patients with diabetes and sepsis remains controversial.Therefore,there is a need for a systematic review and Meta-analysis of existing studies to further evaluate whether metformin can improve mortality and other clinical outcomes in patients with diabetes and sepsis.Objective To systematically evaluate the effects of pre-hospital metformin use on mortality,initial plasma lactate level and organ dysfunction in patients with diabetes and sepsis.Methods PubMed,Embase,Cochrane Library,Web of Science,Scopus,China Biomedical Literature Service System,Wanfang Data,CNKI and other databases were searched by computer for Chinese and English literature on the effects of pre-hospital metformin use on clinical outcomes in patients with sepsis and diabetes from inception to March 15,2023.The test group(MET group)involved adult patients with diabetes and sepsis received pre-hospital metformin use,and the control group(NM group)involved adult patients with diabetes and sepsis who did not receive pre-hospital metformin use.After screening,data extraction and literature quality evaluation were conducted by two researchers,Meta-analysis was performed using RevMan 5.3 software.Results A total of 12 papers were included in this study,involving 12 320 patients with diabetes and sepsis,with Newcastle-Ottawa Scale(NOS)scores of 7-8.The results of Meta-analysis showed that the mortality rate(OR=0.61,95%CI=0.46 to 0.80,P<0.001)and the use rate of vasopressors(OR=0.83,95%CI=0.69 to 0.98,P=0.03)in MET group were lower than those in NM group;there was no significant difference in initial plasma lactate level(MD=0.31,95%CI=-0.12 to 0.75,P=0.16),serum creatinine level(MD=-0.81,95%CI=-0.48 to 0.13,P=0.25),initial blood glucose level(MD=32.94,95%CI=-10.12 to 76.01,P=0.13)and mechanical ventilation(OR=0.90,95%CI=0.77 to 1.06,P=0.23)between the MET group and NM group.Conclusion The pre-hospital use of metformin can reduce the mortality of patients with diabetes and sepsis,and reduce the use rate of vasoppressors in corresponding patients,providing updated evidence that metformin can reduce the mortality of patients with diabetes and sepsis.However,whether it can reduce the sepsis severity score and reduce the maximum dose of norepinephrine in patients with diabetes and sepsis remains to be further studied.

关键词

糖尿病/脓毒症/二甲双胍/临床结局/死亡率/器官功能障碍/Meta分析

Key words

Diabetes mellitus/Sepsis/Metformin/Clinical outcomes/Mortality rate/Organ dysfunction/Meta-analysis

分类

医药卫生

引用本文复制引用

何宇福,佟文英,王芳,李丽霞,何俊冰,邵义明..入院前使用二甲双胍对糖尿病合并脓毒症患者临床结局的影响[J].中国全科医学,2024,27(9):1034-1041,8.

基金项目

国家自然科学基金资助项目(82072151) (82072151)

中国全科医学

OA北大核心CSTPCD

1007-9572

访问量0
|
下载量0
段落导航相关论文